Relationship between physical capacity and match performance in semiprofessional Australian rules football

This study investigated the relationship between physical performance and match performance in Australian Rules Football (ARF). Thirty-six semiprofessional ARF players participated in this study. Physical capacity was measured using a 3-km time trial. Match performance was measured throughout the 2013 season through 2 methods: direct game involvements (DGIs) per minute and a recording of coaches\u27 vote after the game. The main finding of the study was that 3-km time trial performance was a significant predictor of DGI per minute (p ≤ 0.05). In addition, the number of senior games played was also significant in predicting DGI per minute (p ≤ 0.05). Furthermore, the number of senior games significantly correlated with coaches\u27 votes (p ≤ 0.05). There were no significant relationships between 3-km time trial and coaches\u27 vote. The results highlight the importance of developing physical capacity in the preseason period; the players who were better performers in the 3-km time trial had a greater number of DGIs per minute. This information is important to consider in preseason planning to ensure sufficient time is dedicated to developing physical capacity in the training program, as it is directly associated with performance. In addition, this research also highlights the importance of playing experience in relation to team selection. Playing experience, as measured by the number of senior games played, had a significant relationship with both measures of match performance

Plant methods:putting the spotlight on technological innovation in the plant sciences.

Plant Methods is a new journal for plant biologists, specialising in the rapid publication of peer-reviewed articles with a focus on technological innovation in the plant sciences. The aim of Plant Methods is to stimulate the development and adoption of new and improved techniques and research tools in plant biology. We hope to promote more consistent standards in the plant sciences, and make readily accessible laboratory and computer-based research tools available to the whole community. This will be achieved by publishing Research articles, Methodology papers and Reviews using the BioMed Central Open Access publishing model. The journal is supported by a prestigious editorial board, whose members all recognise the importance of technological innovation as a driver for basic science

Deconstructing triplet nucleon-nucleon scattering

Nucleon-nucleon scattering in spin-triplet channels is analysed within an effective field theory where one-pion exchange is treated nonperturbatively. Justifying this requires the identification of an additional low-energy scale in the strength of that potential. Short-range interactions are organised according to the resulting power counting, in which the leading term is promoted to significantly lower order than in the usual perturbative counting. In each channel there is a critical momentum above which the waves probe the singular core of the tensor potential and the new counting is necessary. When the effects of one- and two-pion exchange have been removed using a distorted-wave Born approximation, the residual scattering in waves with L<=2 is well described by the first three terms in the new counting. In contrast, the scattering in waves with L>=3 is consistent with the perturbative counting, at least for energies up to 300 MeV. This pattern is in agreement with estimates of the critical momenta in these channels.Comment: 13 pages, RevTeX, 8 figures, minor clarifications adde

Star Scientists, Innovation and Regional and National Immigration

We follow the careers 1981-2004 of 5401 star scientists listed in ISI HighlyCitedSM as most highly cited by their peers. Their number in a US region or a top-25 science and technology (S&T) country significantly increases the probability of firm entry in the S&T field in which they are working. Stars rather than their disembodied discoveries are key for high-tech entry. Stars become more concentrated over time, moving disproportionately from areas with few peers in their discipline to many, except for a countercurrent of some foreign-born American stars returning home. High impact articles and university articles all tend to diffuse. America has 62 percent of the world’s stars as residents, primarily because of its research universities which produce them. Migration plays a significant role in some developing countries.

Going Public When You Can in Biotechnology

Scientist-entrepreneurs prominent in biotech and other high-technology industries view going public not as a cost-effective source of capital but as a cross between selling a now-proven innovation and winning a lottery. Unlike most empirical IPO analyses confined to those firms that go public, we study substantially all the non-public biotech firms founded up through 1989. The probability that one of these firms goes public in any given year increases with the quality of the firm's science base (use of recombinant DNA technology, number of articles by star scientists as or with firm employees, number of biotech patents), the percentage of eligible firms going public the year the firm was founded as a strategy indicator, recent biotech returns as an indicator of a hot market, and whether or how many rounds of venture capital has been obtained. The same key factors increase the expected proceeds raised from IPOs, but the quality of the firm's science base plays a more dominant role. All firms going public try to look like the next Genentech, but only those with the strong science base necessary for success attract large investments.

Innovation, Competition and Welfare-Enhancing Monopoly

The basic competitive model with freely available technology is suited for static industries but misleading as applied to major innovative economies for which development of new technologies equals in magnitude around 10% of gross domestic investment. We distinguish free generic technology from proprietary technologies resulting from risky investment with uncertain outcome. The totality of possible outcomes drives the national innovation system and the returns to a particular successful technology cannot be compared to its own direct investment costs. Eureka moments are hardly ever self-enabling and incentives are required to motivate investment attempting to turn them into an innovation. The alternative to a valuable proprietary innovation is not the same innovation freely available but the unchanged generic technology. Growth is concentrated in any country at any time in a few firms in a few industries that are achieving metamorphic technological progress as a result of breakthrough innovations. So long as the entry and exit of firms using the generic technology sets the price in an industry, one or more price-taking firms can coexist with proprietary technologies yielding more or less substantial quasi-rents to the sunk development costs. Consumer welfare is increased if an innovator creates a proprietary technology such that the market equilibrium price is reduced and output increased. If the technological breakthrough is sufficiently large for the innovator to drive all generic producers out of the industry and increase output as a wealth-maximizing monopolist, consumer welfare is surely increased. After some time, the innovative technology will diffuse into an imitative generic technology. The best innovators develop a stream of innovations so that technological leaders can maintain their status as dominant firm or monopolist for extended periods of time despite lagged diffusion, and consumers benefit from this stream as well. The economics of an innovative nation are different from those of the no-growth stationary state which we teach and fall back on. We propose an ambitious agenda to integrate major research streams treating innovation as an object of economic analysis into our standard models.

Virtuous Circles of Productivity: Star Bioscientists and the Institutional Transformation of Industry

The most productive (`star') bioscientists possessed intellectual human capital of extraordinary scientific and pecuniary value for some 10-15 yrs after Cohen & Boyer's 1973 founding discovery for biotechnology. This extraordinary value was due to the union of still scarce knowledge of the new research techniques and genius to apply these techniques in valuable ways. As in other sciences, star bioscientists were particularly protective of their ideas in the early years of the revolution, tending to collaborate more within their own institution which slowed diffusion to other scientists. Therefore, close, bench-level working ties between stars and firm scientists were needed to accomplish commercialization of the breakthroughs. Where and when the star scientists were actively producing academic publications is a key determinant of where and when commercial firms began to use biotechnology. The extent of collaboration by a firm's scientists with stars is a powerful predictor of its success: for each 9 articles co-authored by an academic star and firm scientists about 3 more products in development, 1 more on the market and 1550 more employees are estimated. Such collaboration with firms, or employment, also results in significantly higher rates of citation to articles written with the firm. The U.S. scientific and economic infrastructure has been quite effective in fostering and commercializing the bioscientific revolution. To provide an indication of international competitiveness, we estimate stars' distribution, commercial involvement and migration across the top 10 countries in bioscience. These results let us inside the black box to see how scientific breakthroughs become economic growth and consider the implications for policy.

Improved techniques for thermomechanical testing in support of deformation modeling

The feasibility of generating precise thermomechanical deformation data to support constitutive model development was investigated. Here, the requirement is for experimental data that is free from anomalies caused by less than ideal equipment and procedures. A series of exploratory tests conducted on Hastelloy X showed that generally accepted techniques for strain controlled tests were lacking in at least three areas. Specifically, problems were encountered with specimen stability, thermal strain compensation, and temperature/mechanical strain phasing. The source of these difficulties was identified and improved thermomechanical testing techniques to correct them were developed. These goals were achieved by developing improved procedures for measuring and controlling thermal gradients and by designing a specimen specifically for thermomechanical testing. In addition, innovative control strategies were developed to correctly proportion and phase the thermal and mechanical components of strain. Subsequently, the improved techniques were used to generate deformation data for Hastelloy X over the temperature range, 200 to 1000 C